News
The liquid biopsy market is emerging as a revolutionary force in the field of medical diagnostics and oncology. Liquid biopsy refers to a non-invasive technique that analyzes biomarkers, such as ...
HS-AFM avoids amplification artifacts present in PCR or in the sequencing ... as a positive control. Real-time detection was done on a C1000-Touch Thermal Cycler equipped with a CFX96 Real-Time System ...
1d
News-Medical.Net on MSNDiagnostics.ai launches fully-transparent machine learning platform for real-time PCR diagnosticsCE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry's first fully-transparent machine ...
The PCR cycling reactions are carried out in an automated thermocycler, which is capable of heating and cooling the reaction tubes in a short span of time. PCR-Machines are classified depending on ...
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...
Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more ...
PCR-based techniques are methods that rely on the polymerase chain reaction (PCR) to amplify stretches of DNA by creating many identical or near-identical copies. For example, PCR amplification ...
Offering payouts of up to 10,000x your bet, there has never been a better time to spin the reels. Enjoy Weekly AND Monthly Insurance on your losses, up to 45% cash back Daily Free Spins on the ...
The GDP data comes at a time when the Narendra Modi government ... primarily due to reduced government subsidy disbursements. The whole year real GDP growth for FY 2024-25 stood at 6.5%, which ...
The mid-tier and junior gold miners in this sector’s sweet spot for upside potential just achieved their best quarter ever. Profits soared to amazing records, fueled by record gold prices combined ...
Real-world uptake often lags regulatory approval ... and manufacturers maintain the incentive to invest the significant time and capital required to bring a biosimilar medicine to the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results